Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; removing 'idiopathic' from the nomenclature?

Eye (Basingstoke)

Volumn 26, Issue 5, 2012, Pages 623-629

  Lindfield, D ^a   Attfield, K ^b   McElvanney, A ^a  

^a EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

idiopathic; IgG4; immunoglobulin; inflammation; orbit; orbital

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN G4; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

DACRYOCYSTITIS; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC ORBITAL INFLAMMATION; IMMUNOGLOBULIN BLOOD LEVEL; NOMENCLATURE; ORBIT INFLAMMATION; RADIATION DOSE; REVIEW; SYSTEMIC DISEASE; TREATMENT RESPONSE; VISUAL IMPAIRMENT;

EID: 84862517090     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2012.4     Document Type: Review

References (49)

1. Gordon LK. Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye 2006; 20: 1196-1206. (Pubitemid 44515582)
2. Baert AL, Sartor K. Imaging of Orbital and Visual Pathway Pathology, 1st ed. Springer: Berlin, Heidelberg, New York, 2002. ISBN: 978-3-540-63302-0.
3. Jakobiec FA, Font RL. Orbit. In: Spencer WH (ed). Ophthalmic Pathology: An Atlas and Textbook, 4th ed. WB Saunders: Philadelphia, PA, 1996, pp 2822-2844.
4. Gleason JE. Idiopathic myositis involving the intraocular muscles. Ophthalmol Rec 1903; 12: 471-478.
5. Busse O, Hochheim W. Cited by Dunnington JH, Berke RN. Exophthalmos due to chronic orbital myositis. Arch Ophthalmol 1943; 30: 446-466.
6. Birch-Hirschfeld A. Zur diagnostic and pathologic der orbital tumoren. Ber Zusammenkunft Dtsch Ophthalmol Ges 1905; 32: 127-135.
7. Guthoff RF, Katowitz JA. Oculoplastics and Orbit: Aesthetic and Functional Oculofacial Plastic Problem-Solving in the 21st Century, 3rd Vol Springer: Berlin, Heidelberg, 2010. ISBN 978-3-540-85541-5.
8. Rose GE. A personal view: probability in medicine, levels of (un)(certainty, and the diagnosis of orbital disease (with particular reference to orbital 'pseudotumor'). Arch Ophthalmol 2007; 125: 1171-1172.
9. Hashira S, Okitsu-Negishi S, Yoshino K. Placental transfer of IgG subclasses in a Japanese population. Pediatr Int 2000; 42(4): 337-342.
10. Jeannin P, Lecoanet S, Delneste Y, Gauchat J, Bonnefoy J. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol 1998; 160: 1555-3561.
11. Hussain R, Poindexter R, Ottesen E. Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J Immunol 1992; 148: 2731-2737.
12. Kamisawa T. IgG4-positive plasma cells specifically infiltrate various organs in autoimmune pancreatitis. Pancreas 2004; 29(2): 167-168. (Pubitemid 38971809)
13. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol 2008; 14(25): 3948-3955.
14. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T et al. High serum IgG4 concentrations in patients with sclerosing cholangitis. N Engl J Med 2001; 334(10): 732-738. (Pubitemid 32204991)
15. Zen Y, Fujii T, Sato Y, Masuda S, Nakanuma Y. Pathological classification of hepatic inflammatory pseudotumour with respect to IgG4-related disease. Mod Pathol 2007; 20(8): 884-894. (Pubitemid 47077274)
16. Kitagawa S, Zen Y, Harada K, Sasaki M, Sato Y, Minato H et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner's Tumour). Am J Surg Pathol 2005; 29(6): 783-791. (Pubitemid 40734427)
17. Kamisawsa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 2006; 6(1-2): 132-137.
18. Kobayashi H, Shimokawaji T, Kanoh S, Motoyoshi K, Aida S. IgG4-positive pulmonary disease. J Thorac Imaging 2007; 22: 360-362. (Pubitemid 350196960)
19. Watson SJ, Jenkins DA, Bellamy CO. Nephropathy in IgG4- related systemic disease. Am J Surg Pathol 2006; 30: 1472-1477. (Pubitemid 44655485)
20. Yamarnoto M, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, Takahashi H et al. Elevated IgG4 concentrations in serum of patients with Mukulicz's disease. Scan J Rheumatol 2004; 33(6): 432-433. (Pubitemid 40006895)
21. Takahira M, Kawano M, Zen Y, Minato H, Yamada K, Sugiyama K. IgG4-related chronic sclerosing dacryoadenitis. Arch Ophthalmol 2007; 125(11): 1575-1578. (Pubitemid 350106698)
22. Plaza J, Garrity J, Dogan A, Amanthamurthy A, Witzig T, Salomao D. Orbital inflammation with IgG4-positive plasma cells; manifestations of IgG4 systemic disease. Arch Ophthalmol 2011; 129(4): 421-428.
23. Sato Y, Ohshima K, Ichimura K, SatoM, Yamadori I, Tanaka T et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int 2008; 58: 465-470. (Pubitemid 351952020)
24. Cheuk W, Yuen HK, Chan AC, Shih LY, Kuo TT, Ma MW et al. Ocular adnexal lymphoma associated with IgG4 + chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol 2008; 32(8): 1159-1167.
25. Jakobiec FA. Ocular adnexal lymphoid tumours: progress in need of clarification. Am J Ophthalmol 2008; 145(6): 941-950.
26. Matsuo T, Ichimura K, Sato Y, Tanimoto Y, Kiura K, Kanzawa S et al. Immunoglobulin G4 (IgG4)-positive or -negative ocular adnexal benign lymhoid lesions in relation to systemic involvement. J Clinc Exp Hematopathol 2010; 50(2): 129-142.
27. Singh K, Rajan KD, Eberhart C. Orbital necrobiotic xanthogranuloma associated with systemic IgG4 disease. Oc Immunol Inflamm 2010; 18(5): 373-378.
28. Mehta M, Jakobiec F, Fay A. Idiopathic fibroinflammatory disease of the face, eyelids, and periorbital membrane with immunoglobulin G4-positive plasma cells. Arch Pathol Lab Med 2009; 133: 1251-1255.
29. Khosroshahi A, Stone JH. A clinical overview of IgG4- related systemic disease. Curr Opin Rheum 2011; 23: 57-66.
30. McCarthy JM, White VA, Harris G, Simons KB, Kennerdell J, Rootman J. Idiopathic sclerosing inflammation of the orbit: immunohistologic analysis and comparison with retroperitoneal fibrosis. Mod Pathol 1993; 6(5): 581-587.
31. Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Yamamoto H et al. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod Rheumatol 2006; 16: 335-340. (Pubitemid 44921578)
32. Espinoza G. Orbital inflammatory pseudotumors: etiology, differential diagnosis and management. Curr Rheumatol Rep 2010; 12: 443-447.
33. Papi G, LiVolsi VA. Current concepts on Reidel thyroiditis. Am J Clin Pathol 2004; 121(Suppl 1): 50-63.
34. Ochoa ER, Harris NL, Pilch BZ. Marginal zone B-cell lymphoma of the salivary gland arising in chronic sclerosing sialadentiis (Kuttner tumor). Am J Surg Pathol 2001; 25: 1546-1550. (Pubitemid 33096971)
35. Oyama T, Takizawa J, Nakamura N, Aoki S, Aizawa Y, Abe H. Multifocal muscosa-associated lymphoid tissue lymphoma associated with IgG4-related disease: a case report. Jpn J Ophthalmol 2011; 55: 304-306.
36. Wieczorek R, Jacobiec FA, Sacks EH, Knowles DM. The immunoarchitecture of the normal human lacrimal gland: relevancy for understanding pathologic conditions. Ophthalmology 1988; 95(1): 100-109. (Pubitemid 18052409)
37. Zhang L, Notohora K, Levy MJ, Chari ST, Smyrk TC. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007; 20(1): 23-28. (Pubitemid 44967946)
38. Venkataraman G, Rizzo KA, Chavez JJ, Streubel B, Raffeld M, Jaffe ES et al. Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases. Mod Pathol 2011; 24(3): 355-366.
39. Kanda G, Ryu T, Shirai T, Ijichi M, Hishima T, Kitamura S et al. Peripheral T-cell lymphoma that developed during the followup of IgG4-related disease. Intern Med 2011; 50: 155-160.
40. Cheuk W, Tam FK, Chan AN, Luk IS, Yuen AP, Chan WK et al. Idiopathic cervical fibrosis-a new member of IgG4- related sclerosing diseases: report of 4 cases, 1 complicated by composite lymphoma. Am J Surg Pathol 2010; 34(11): 1678-1685.
41. Sato Y, Takata K, Ichimura K, Tanaka K, Morito T, TamuraM et al. IgG4-producing marginal zone B-cell lymphomas. Int J Hematol 2008; 88: 428-433.
42. Kubota T, Moritani S, Yoshino T, Nagai H, Terasaki H. Ocular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells. J Clin Pathol 2010; 63: 1059-1065.
43. Jacobs D, Galetta S. Diagnosis and management of orbital pseudotumor. Curr Opin Ophthalmol 2002; 13: 347-351. (Pubitemid 35397641)
44. Mombaerts I, Sclingemann R, Goldschmeding R, Koorneef L. Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology 1996; 103: 521-528. (Pubitemid 26085906)
45. Char D, Miller T. Orbital pseudotumor; fine needle aspiration biopsy and response to therapy. Ophthalmology 1993; 100: 1702-1710. (Pubitemid 23335936)
46. Kennerdell J, Johnson B, Deutsch M. Radiation treatment of orbital lymphoid hyperplasia. Ophthalmology 1979; 86: 942-947. (Pubitemid 10167527)
47. Sergott R, Glaser J, Charyulu K. Radiotherapy for idiopathic inflammatory orbital pseudotumor: indications and results. Arch Ophthalmol 1981; 99: 8536.
48. Orcutt J, Garner A, Henk J,Wright J. Treatment of idiopathic inflammatory orbital pseudotumors by radiotherapy. Br J Ophthalmol 1983; 67: 570-574. (Pubitemid 13036811)
49. Masaki Y, Kurose N, Umehara H. IgG4-related disease: a novel lymphoproliferative disorder discovered and established in japan in the 21st century. J Clin Exp Hematopathol 2011; 51(1): 13-20.